ArticleScientific reports2018

A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells.

Charlotte U Brey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.